TAVR for All? The Surgical Perspective
In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the biop...
Ausführliche Beschreibung
Autor*in: |
Xiling Zhang [verfasserIn] Thomas Puehler [verfasserIn] Derk Frank [verfasserIn] Janarthanan Sathananthan [verfasserIn] Stephanie Sellers [verfasserIn] David Meier [verfasserIn] Marcus Both [verfasserIn] Philipp Blanke [verfasserIn] Hatim Seoudy [verfasserIn] Mohammed Saad [verfasserIn] Oliver J. Müller [verfasserIn] Lars Sondergaard [verfasserIn] Georg Lutter [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) |
---|
Übergeordnetes Werk: |
In: Journal of Cardiovascular Development and Disease - MDPI AG, 2014, 9(2022), 7, p 223 |
---|---|
Übergeordnetes Werk: |
volume:9 ; year:2022 ; number:7, p 223 |
Links: |
---|
DOI / URN: |
10.3390/jcdd9070223 |
---|
Katalog-ID: |
DOAJ036127671 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ036127671 | ||
003 | DE-627 | ||
005 | 20240414135952.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcdd9070223 |2 doi | |
035 | |a (DE-627)DOAJ036127671 | ||
035 | |a (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC666-701 | |
100 | 0 | |a Xiling Zhang |e verfasserin |4 aut | |
245 | 1 | 0 | |a TAVR for All? The Surgical Perspective |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. | ||
650 | 4 | |a aortic valve stenosis | |
650 | 4 | |a transcatheter aortic valve replacement (TAVR) | |
650 | 4 | |a transcatheter aortic valve implantation (TAVI) | |
650 | 4 | |a surgical aortic valve replacement (SAVR) | |
650 | 4 | |a low risk | |
650 | 4 | |a intermediate risk | |
653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
700 | 0 | |a Thomas Puehler |e verfasserin |4 aut | |
700 | 0 | |a Derk Frank |e verfasserin |4 aut | |
700 | 0 | |a Janarthanan Sathananthan |e verfasserin |4 aut | |
700 | 0 | |a Stephanie Sellers |e verfasserin |4 aut | |
700 | 0 | |a David Meier |e verfasserin |4 aut | |
700 | 0 | |a Marcus Both |e verfasserin |4 aut | |
700 | 0 | |a Philipp Blanke |e verfasserin |4 aut | |
700 | 0 | |a Hatim Seoudy |e verfasserin |4 aut | |
700 | 0 | |a Mohammed Saad |e verfasserin |4 aut | |
700 | 0 | |a Oliver J. Müller |e verfasserin |4 aut | |
700 | 0 | |a Lars Sondergaard |e verfasserin |4 aut | |
700 | 0 | |a Georg Lutter |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Journal of Cardiovascular Development and Disease |d MDPI AG, 2014 |g 9(2022), 7, p 223 |w (DE-627)790616017 |w (DE-600)2777082-5 |x 23083425 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2022 |g number:7, p 223 |
856 | 4 | 0 | |u https://doi.org/10.3390/jcdd9070223 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2308-3425/9/7/223 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2308-3425 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 9 |j 2022 |e 7, p 223 |
author_variant |
x z xz t p tp d f df j s js s s ss d m dm m b mb p b pb h s hs m s ms o j m ojm l s ls g l gl |
---|---|
matchkey_str |
article:23083425:2022----::aroalhsriapr |
hierarchy_sort_str |
2022 |
callnumber-subject-code |
RC |
publishDate |
2022 |
allfields |
10.3390/jcdd9070223 doi (DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 DE-627 ger DE-627 rakwb eng RC666-701 Xiling Zhang verfasserin aut TAVR for All? The Surgical Perspective 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system Thomas Puehler verfasserin aut Derk Frank verfasserin aut Janarthanan Sathananthan verfasserin aut Stephanie Sellers verfasserin aut David Meier verfasserin aut Marcus Both verfasserin aut Philipp Blanke verfasserin aut Hatim Seoudy verfasserin aut Mohammed Saad verfasserin aut Oliver J. Müller verfasserin aut Lars Sondergaard verfasserin aut Georg Lutter verfasserin aut In Journal of Cardiovascular Development and Disease MDPI AG, 2014 9(2022), 7, p 223 (DE-627)790616017 (DE-600)2777082-5 23083425 nnns volume:9 year:2022 number:7, p 223 https://doi.org/10.3390/jcdd9070223 kostenfrei https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 kostenfrei https://www.mdpi.com/2308-3425/9/7/223 kostenfrei https://doaj.org/toc/2308-3425 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 7, p 223 |
spelling |
10.3390/jcdd9070223 doi (DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 DE-627 ger DE-627 rakwb eng RC666-701 Xiling Zhang verfasserin aut TAVR for All? The Surgical Perspective 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system Thomas Puehler verfasserin aut Derk Frank verfasserin aut Janarthanan Sathananthan verfasserin aut Stephanie Sellers verfasserin aut David Meier verfasserin aut Marcus Both verfasserin aut Philipp Blanke verfasserin aut Hatim Seoudy verfasserin aut Mohammed Saad verfasserin aut Oliver J. Müller verfasserin aut Lars Sondergaard verfasserin aut Georg Lutter verfasserin aut In Journal of Cardiovascular Development and Disease MDPI AG, 2014 9(2022), 7, p 223 (DE-627)790616017 (DE-600)2777082-5 23083425 nnns volume:9 year:2022 number:7, p 223 https://doi.org/10.3390/jcdd9070223 kostenfrei https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 kostenfrei https://www.mdpi.com/2308-3425/9/7/223 kostenfrei https://doaj.org/toc/2308-3425 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 7, p 223 |
allfields_unstemmed |
10.3390/jcdd9070223 doi (DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 DE-627 ger DE-627 rakwb eng RC666-701 Xiling Zhang verfasserin aut TAVR for All? The Surgical Perspective 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system Thomas Puehler verfasserin aut Derk Frank verfasserin aut Janarthanan Sathananthan verfasserin aut Stephanie Sellers verfasserin aut David Meier verfasserin aut Marcus Both verfasserin aut Philipp Blanke verfasserin aut Hatim Seoudy verfasserin aut Mohammed Saad verfasserin aut Oliver J. Müller verfasserin aut Lars Sondergaard verfasserin aut Georg Lutter verfasserin aut In Journal of Cardiovascular Development and Disease MDPI AG, 2014 9(2022), 7, p 223 (DE-627)790616017 (DE-600)2777082-5 23083425 nnns volume:9 year:2022 number:7, p 223 https://doi.org/10.3390/jcdd9070223 kostenfrei https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 kostenfrei https://www.mdpi.com/2308-3425/9/7/223 kostenfrei https://doaj.org/toc/2308-3425 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 7, p 223 |
allfieldsGer |
10.3390/jcdd9070223 doi (DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 DE-627 ger DE-627 rakwb eng RC666-701 Xiling Zhang verfasserin aut TAVR for All? The Surgical Perspective 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system Thomas Puehler verfasserin aut Derk Frank verfasserin aut Janarthanan Sathananthan verfasserin aut Stephanie Sellers verfasserin aut David Meier verfasserin aut Marcus Both verfasserin aut Philipp Blanke verfasserin aut Hatim Seoudy verfasserin aut Mohammed Saad verfasserin aut Oliver J. Müller verfasserin aut Lars Sondergaard verfasserin aut Georg Lutter verfasserin aut In Journal of Cardiovascular Development and Disease MDPI AG, 2014 9(2022), 7, p 223 (DE-627)790616017 (DE-600)2777082-5 23083425 nnns volume:9 year:2022 number:7, p 223 https://doi.org/10.3390/jcdd9070223 kostenfrei https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 kostenfrei https://www.mdpi.com/2308-3425/9/7/223 kostenfrei https://doaj.org/toc/2308-3425 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 7, p 223 |
allfieldsSound |
10.3390/jcdd9070223 doi (DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 DE-627 ger DE-627 rakwb eng RC666-701 Xiling Zhang verfasserin aut TAVR for All? The Surgical Perspective 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system Thomas Puehler verfasserin aut Derk Frank verfasserin aut Janarthanan Sathananthan verfasserin aut Stephanie Sellers verfasserin aut David Meier verfasserin aut Marcus Both verfasserin aut Philipp Blanke verfasserin aut Hatim Seoudy verfasserin aut Mohammed Saad verfasserin aut Oliver J. Müller verfasserin aut Lars Sondergaard verfasserin aut Georg Lutter verfasserin aut In Journal of Cardiovascular Development and Disease MDPI AG, 2014 9(2022), 7, p 223 (DE-627)790616017 (DE-600)2777082-5 23083425 nnns volume:9 year:2022 number:7, p 223 https://doi.org/10.3390/jcdd9070223 kostenfrei https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 kostenfrei https://www.mdpi.com/2308-3425/9/7/223 kostenfrei https://doaj.org/toc/2308-3425 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 7, p 223 |
language |
English |
source |
In Journal of Cardiovascular Development and Disease 9(2022), 7, p 223 volume:9 year:2022 number:7, p 223 |
sourceStr |
In Journal of Cardiovascular Development and Disease 9(2022), 7, p 223 volume:9 year:2022 number:7, p 223 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk Diseases of the circulatory (Cardiovascular) system |
isfreeaccess_bool |
true |
container_title |
Journal of Cardiovascular Development and Disease |
authorswithroles_txt_mv |
Xiling Zhang @@aut@@ Thomas Puehler @@aut@@ Derk Frank @@aut@@ Janarthanan Sathananthan @@aut@@ Stephanie Sellers @@aut@@ David Meier @@aut@@ Marcus Both @@aut@@ Philipp Blanke @@aut@@ Hatim Seoudy @@aut@@ Mohammed Saad @@aut@@ Oliver J. Müller @@aut@@ Lars Sondergaard @@aut@@ Georg Lutter @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
790616017 |
id |
DOAJ036127671 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ036127671</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414135952.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/jcdd9070223</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ036127671</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC666-701</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xiling Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">TAVR for All? The Surgical Perspective</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aortic valve stenosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">transcatheter aortic valve replacement (TAVR)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">transcatheter aortic valve implantation (TAVI)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">surgical aortic valve replacement (SAVR)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">low risk</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intermediate risk</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the circulatory (Cardiovascular) system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thomas Puehler</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Derk Frank</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janarthanan Sathananthan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephanie Sellers</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David Meier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcus Both</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Philipp Blanke</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hatim Seoudy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mohammed Saad</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Oliver J. Müller</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lars Sondergaard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Georg Lutter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Cardiovascular Development and Disease</subfield><subfield code="d">MDPI AG, 2014</subfield><subfield code="g">9(2022), 7, p 223</subfield><subfield code="w">(DE-627)790616017</subfield><subfield code="w">(DE-600)2777082-5</subfield><subfield code="x">23083425</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:7, p 223</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/jcdd9070223</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2308-3425/9/7/223</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2308-3425</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2022</subfield><subfield code="e">7, p 223</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Xiling Zhang |
spellingShingle |
Xiling Zhang misc RC666-701 misc aortic valve stenosis misc transcatheter aortic valve replacement (TAVR) misc transcatheter aortic valve implantation (TAVI) misc surgical aortic valve replacement (SAVR) misc low risk misc intermediate risk misc Diseases of the circulatory (Cardiovascular) system TAVR for All? The Surgical Perspective |
authorStr |
Xiling Zhang |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)790616017 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC666-701 |
illustrated |
Not Illustrated |
issn |
23083425 |
topic_title |
RC666-701 TAVR for All? The Surgical Perspective aortic valve stenosis transcatheter aortic valve replacement (TAVR) transcatheter aortic valve implantation (TAVI) surgical aortic valve replacement (SAVR) low risk intermediate risk |
topic |
misc RC666-701 misc aortic valve stenosis misc transcatheter aortic valve replacement (TAVR) misc transcatheter aortic valve implantation (TAVI) misc surgical aortic valve replacement (SAVR) misc low risk misc intermediate risk misc Diseases of the circulatory (Cardiovascular) system |
topic_unstemmed |
misc RC666-701 misc aortic valve stenosis misc transcatheter aortic valve replacement (TAVR) misc transcatheter aortic valve implantation (TAVI) misc surgical aortic valve replacement (SAVR) misc low risk misc intermediate risk misc Diseases of the circulatory (Cardiovascular) system |
topic_browse |
misc RC666-701 misc aortic valve stenosis misc transcatheter aortic valve replacement (TAVR) misc transcatheter aortic valve implantation (TAVI) misc surgical aortic valve replacement (SAVR) misc low risk misc intermediate risk misc Diseases of the circulatory (Cardiovascular) system |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Journal of Cardiovascular Development and Disease |
hierarchy_parent_id |
790616017 |
hierarchy_top_title |
Journal of Cardiovascular Development and Disease |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)790616017 (DE-600)2777082-5 |
title |
TAVR for All? The Surgical Perspective |
ctrlnum |
(DE-627)DOAJ036127671 (DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4 |
title_full |
TAVR for All? The Surgical Perspective |
author_sort |
Xiling Zhang |
journal |
Journal of Cardiovascular Development and Disease |
journalStr |
Journal of Cardiovascular Development and Disease |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
author_browse |
Xiling Zhang Thomas Puehler Derk Frank Janarthanan Sathananthan Stephanie Sellers David Meier Marcus Both Philipp Blanke Hatim Seoudy Mohammed Saad Oliver J. Müller Lars Sondergaard Georg Lutter |
container_volume |
9 |
class |
RC666-701 |
format_se |
Elektronische Aufsätze |
author-letter |
Xiling Zhang |
doi_str_mv |
10.3390/jcdd9070223 |
author2-role |
verfasserin |
title_sort |
tavr for all? the surgical perspective |
callnumber |
RC666-701 |
title_auth |
TAVR for All? The Surgical Perspective |
abstract |
In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. |
abstractGer |
In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. |
abstract_unstemmed |
In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
7, p 223 |
title_short |
TAVR for All? The Surgical Perspective |
url |
https://doi.org/10.3390/jcdd9070223 https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4 https://www.mdpi.com/2308-3425/9/7/223 https://doaj.org/toc/2308-3425 |
remote_bool |
true |
author2 |
Thomas Puehler Derk Frank Janarthanan Sathananthan Stephanie Sellers David Meier Marcus Both Philipp Blanke Hatim Seoudy Mohammed Saad Oliver J. Müller Lars Sondergaard Georg Lutter |
author2Str |
Thomas Puehler Derk Frank Janarthanan Sathananthan Stephanie Sellers David Meier Marcus Both Philipp Blanke Hatim Seoudy Mohammed Saad Oliver J. Müller Lars Sondergaard Georg Lutter |
ppnlink |
790616017 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/jcdd9070223 |
callnumber-a |
RC666-701 |
up_date |
2024-07-03T18:50:53.362Z |
_version_ |
1803584959533809664 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ036127671</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414135952.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/jcdd9070223</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ036127671</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9d49de55c1b24019aa3eb2b64f5aafa4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC666-701</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xiling Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">TAVR for All? The Surgical Perspective</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aortic valve stenosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">transcatheter aortic valve replacement (TAVR)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">transcatheter aortic valve implantation (TAVI)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">surgical aortic valve replacement (SAVR)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">low risk</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intermediate risk</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the circulatory (Cardiovascular) system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thomas Puehler</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Derk Frank</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janarthanan Sathananthan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephanie Sellers</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David Meier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcus Both</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Philipp Blanke</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hatim Seoudy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mohammed Saad</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Oliver J. Müller</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lars Sondergaard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Georg Lutter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Cardiovascular Development and Disease</subfield><subfield code="d">MDPI AG, 2014</subfield><subfield code="g">9(2022), 7, p 223</subfield><subfield code="w">(DE-627)790616017</subfield><subfield code="w">(DE-600)2777082-5</subfield><subfield code="x">23083425</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:7, p 223</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/jcdd9070223</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9d49de55c1b24019aa3eb2b64f5aafa4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2308-3425/9/7/223</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2308-3425</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2022</subfield><subfield code="e">7, p 223</subfield></datafield></record></collection>
|
score |
7.400692 |